Literature DB >> 10749604

Intraperitoneal chemotherapy: biologic implications for clinical outcome.

J M Daly.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10749604      PMCID： PMC1421019          DOI： 10.1097/00000658-200004000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  8 in total

1.  Potentially curative surgery of colon cancer: patterns of failure and survival.

Authors:  B D Minsky; C Mies; T A Rich; A Recht; J T Chaffey
Journal:  J Clin Oncol       Date:  1988-01       Impact factor: 44.544

2.  Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial.

Authors:  J C Vaillant; B Nordlinger; S Deuffic; J P Arnaud; E Pelissier; J P Favre; D Jaeck; G Fourtanier; J P Grandjean; P Marre; C Letoublon
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

3.  Sites of recurrent tumour after 'curative' colorectal surgery: implications for adjuvant therapy.

Authors:  J M Gilbert; I Jeffrey; M Evans; A E Kark
Journal:  Br J Surg       Date:  1984-03       Impact factor: 6.939

4.  Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators.

Authors: 
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

5.  Incidence of free colorectal cancer cells on the peritoneal surface.

Authors:  M J Solomon; M Egan; R A Roberts; J Philips; P Russell
Journal:  Dis Colon Rectum       Date:  1997-11       Impact factor: 4.585

6.  Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden.

Authors:  P Pisani; D M Parkin; J Ferlay
Journal:  Int J Cancer       Date:  1993-12-02       Impact factor: 7.396

7.  A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.

Authors:  D P Kelsen; L Saltz; A M Cohen; T J Yao; W Enker; W Tong; Y Tao; J R Bertino
Journal:  Cancer       Date:  1994-10-15       Impact factor: 6.860

8.  Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.

Authors:  W Scheithauer; G V Kornek; A Marczell; J Karner; G Salem; R Greiner; D Burger; F Stöger; J Ritschel; E Kovats; H M Vischer; B Schneeweiss; D Depisch
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.